A Review of Alternative Treatment Options in Diabetic Polyneuropathy.
diabetes
diabetic polyneuropathy
natural supplements
non-pharmacological treatments
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
21 Apr 2021
21 Apr 2021
Historique:
entrez:
27
5
2021
pubmed:
28
5
2021
medline:
28
5
2021
Statut:
epublish
Résumé
Currently there is no recognized curative treatment for diabetic polyneuropathy (DPN). Strict glucose control and symptomatic pain relief are the first line management routes. DPN is a common complication of diabetes and has a major detrimental influence on the quality of life (QOL) for many patients. Due to the scope of the problem, it is imperative that treatment options which impede DPN's progression and restore sensorineural function should be researched comprehensively and made available to the masses at an economical cost. We reviewed a multitude of atypical treatment options for DPN including capsaicin, lidocaine, acupuncture, electrical nerve stimulation, alpha lipoic acid, benfotiamine, and acetyl-l-carnitine and explored the evidence to date regarding their safety and efficacy. Most of these options have been around for a long time and have promising pilot studies or small-scale trials focused on DPN treatment.
Identifiants
pubmed: 34040901
doi: 10.7759/cureus.14600
pmc: PMC8139599
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e14600Informations de copyright
Copyright © 2021, Zaheer et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Diabetes Care. 1992 Jan;15(1):8-14
pubmed: 1737545
Acupunct Med. 2014 Jun;32(3):242-9
pubmed: 24657491
Nat Rev Endocrinol. 2018 Feb;14(2):88-98
pubmed: 29219149
Biopsychosoc Med. 2014 Jan 20;8(1):4
pubmed: 24444292
F1000Res. 2016 Apr 25;5:
pubmed: 27158461
Expert Rev Neurother. 2013 Aug;13(8):925-36
pubmed: 23965166
Pain Med. 2019 Nov 1;20(11):2292-2302
pubmed: 31127837
Drugs R D. 2002;3(4):223-31
pubmed: 12455197
Diabetes Nutr Metab. 2004 Jun;17(3):163-8
pubmed: 15334794
Arch Neurol. 2004 Jun;61(6):914-8
pubmed: 15210530
Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):600-5
pubmed: 18473286
Diabetes Care. 2011 Sep;34(9):2054-60
pubmed: 21775755
J Diabetes Res. 2015;2015:189857
pubmed: 26345602
Molecules. 2016 Jun 28;21(7):
pubmed: 27367653
J Diabetes Investig. 2016 Sep;7(5):777-85
pubmed: 27180954
Curr Diab Rep. 2019 Aug 27;19(10):86
pubmed: 31456118
Curr Med Chem. 2004 May;11(9):1135-46
pubmed: 15134511
Diabetes Care. 2005 Oct;28(10):2378-83
pubmed: 16186266
Nat Rev Endocrinol. 2016 May;12(5):263-273
pubmed: 27020257
Diabetes Care. 1997 Nov;20(11):1702-5
pubmed: 9353612
CNS Drugs. 2007;21 Suppl 1:31-8; discussion 45-6
pubmed: 17696591
J Pain. 2017 Jan;18(1):42-53
pubmed: 27746370
Rev Pain. 2007 Aug;1(1):7-11
pubmed: 26526976
CNS Drugs. 2007;21 Suppl 1:3-12; discussion 45-6
pubmed: 17696588
Diabetes Care. 2006 Nov;29(11):2365-70
pubmed: 17065669
Neurology. 2010 Jan 12;74(2):173-6
pubmed: 20042705
Biomolecules. 2019 Aug 09;9(8):
pubmed: 31405030
Curr Clin Pharmacol. 2011 Nov;6(4):260-73
pubmed: 22082324
Ann Neurol. 2013 Sep;74(3):397-403
pubmed: 23929529
Int J Clin Pharmacol Ther. 2005 Feb;43(2):71-7
pubmed: 15726875
J Gen Physiol. 2009 Jan;133(1):1-15
pubmed: 19088384
Diabetes Care. 2005 Jan;28(1):89-94
pubmed: 15616239
Neurology. 2011 May 17;76(20):1758-65
pubmed: 21482920
Diabet Med. 2004 Feb;21(2):114-21
pubmed: 14984445
Acupunct Med. 2007 Jun;25(1-2):11-7
pubmed: 17641562
Pain Med. 2011 Jun;12(6):953-60
pubmed: 21627767
Pain Med. 2003 Dec;4(4):321-30
pubmed: 14750908
Exp Clin Endocrinol Diabetes. 2001;109(6):330-6
pubmed: 11571671
Diabetes Res Clin Pract. 1998 Feb;39(2):115-21
pubmed: 9597381
Lancet. 2014 Mar 22;383(9922):1068-83
pubmed: 24315620